In agreement with these results, Riou and colleagues demonstrated in TB-COVID-19 co-infection impaired SARS-CoV-2-specific and Mtb-specific CD4+ T cells with reduced polyfunctional cell potentials, proliferation cell capacity, and augmented cell activation markers (311). This evidence concerns the gene CD4 and tuberculosis.